🏥 Health
6d ago
Chemo Combo Wins in Ovarian Cancer, But Single-Agent Therapy Still in the Game
Source ↗
👁 0
💬 0
(MedPage Today) -- SAN JUAN, PUERTO RICO -- A negative study in low-grade serous ovarian cancer might have uncovered a pathway toward more effective treatment for a large subgroup of patients, according to the NRG-GY019 trial.
The randomized...
The randomized...
Comments (0)